Status:
NOT_YET_RECRUITING
Vaped Phenanthrene
Lead Sponsor:
University of Minnesota
Conditions:
Former Smoker
Non-Smoker
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Some people who used to smoke cigarettes continue to be at higher risk of developing lung cancer, even years after quitting. This study will look to see if a specific chemical, phenanthrene, is broken...
Eligibility Criteria
Inclusion
- \> 21 years of age
- In good physical \& mental health
- In stable physical \& mental health
- Have tried vaping
- Former daily cigarette smokers who quit 1-20 year ago
- Non-smokers who have not used tobacco or nicotine products
Exclusion
- Has any respiratory disease (ex - asthma, COPD, etc...)
- Has/had high blood pressure
- Has/had liver disease
- Has/had cancer
- Has experience negative effects when vaped previously
- Pregnant or nursing
Key Trial Info
Start Date :
February 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07134426
Start Date
February 1 2026
End Date
June 30 2028
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455